Other

Royalty Pharma lets Elan takeover bid expire

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

Health

2008 initiative had minimal impact on pressure ulcer charges

(HealthDay)—The 2008 Hospital-Acquired Conditions Initiative (HACI) payment changes for pressure ulcers have had a minimal effect, according to a study published in the July issue of the Journal of the American Geriatrics ...

Oncology & Cancer

Bundle payment model analysis of emerging breast cancer screening

Bundled payments have been touted as mechanisms to optimize quality and costs. A prior feasibility study evaluating bundled payments for screening mammography episodes predated widespread adoption of digital breast tomosynthesis ...

Other

Elan moves to deter takeover bid

(AP)—Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri.

page 22 from 25